Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells

Journal of Endocrinology

Volumn 160, Issue 3, 1999, Pages 483-490

  Gloddek, J ^b   Pagotto, U ^b   Paez Pereda, M ^b   Arzt, E ^a,b   Stalla, G K ^b   Renner, U ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 6; MIFEPRISTONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL FUNCTION; CELL GROWTH; ENDOTHELIUM CELL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

EID: 0242705311     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1600483     Document Type: Article

References (39)

1. Allaerts W, Carmeliet P & Denef C 1990 New perspective's in the function of pituitary folliculo-stellate cells. Molecular and Cellular Endocrinology 71 73-81.
2. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U & Stalla GK 1993 Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6. Endocrinology 132 459-467.
3. Banerjee SK, Sarkar DK, Weston AP, De A & Campbell DR 1997 Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-mitiated tumor angiogenesis. Carcinogenesis 18 1155-1161.
4. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU & Oldfleld EH 1993 Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. Journal of Clinical Investigation 91 153-159.
5. Carmeliet P, Vankelecom H, Van Damme J, Billiau A & Denef C 1991 Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology 53 29-34.
6. Claffey KP & Robinson GS 1996 Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Reviews 15 165-176.
7. Cohen T, Nahari D, Weiss Cerem L, Neufeld G & Levi B-Z 1996 Interleukin 6 induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry 271 736-741.
8. Cullinan-Bove K & Koos RD 1993 Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133 829-837.
9. Dvorak HF, Brown LF, Detmar M & Dvorak AM 1995 Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 146 1029-1039.
10. Farnoud MR, Kujas M, Derome P, Racadot J, Peillon F & Li JY 1994 Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas. Virchows Archiv A 424 75-82.
11. Ferrara N & Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothdial cells. Biochemical and Biophysical Research Communications 161 851-858.
12. Ferrara N & Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocrine Reviews 18 4-25.
13. Ferrara N, Schweigerer L, Neufeld G, Mitchell R & Gospodarowicz D 1987 Pituitary follicular cells produce basic tibroblast growth factor. Proceedings of the National Academy of Sciences of the USA 84 5773-5777.
14. Ferrara N, Winer J & Henzel WJ 1992 Pituitary follicular cells secrete an inhibitor of aortic endothelial tell growth: identification as leukemia inhibitor factor. Proceedings of the National Academy of Sciences of the USA 89 698-702.
15. Heiss JD, Papavassiliou E, Merill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA & Oldfield EH 1996 Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Journal of Clinical Investigation 98 1400-1408.
16. Inoue K, Matsumoto H, Koyama C, Shibata K, Nakazato Y & Ito A 1992 Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor. Endocrinology 131 3110-3116.
17. Jabbour HN, Boddy SC & Lincoln GA 1997 Flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control. Molecular and Cellular Endocrinology 134 91-100.
18. Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P & Weetman AP 1994 Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 78 180-187.
19. Kim K, Li B, Winer J, Armanini M, Gillett N & Phillips H 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 841-844.
20. Klagsbrun M & D'Amore PA 1996 Vascular endothelial growth factor and its receptors. Cytokine and Growth Factor Reviews 7 259-270.
21. Koyama C, Matsumoto H, Sakai T, Wakabayashi K, Ito A, Couch EF & Inoue K 1995 Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary growth in nude mice. Endocrine Pathology 6 67-75.
22. Leung DW, Cachianes G, Kuang W-J, Goeddel DV & Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 1306-1309.
23. Mann F, Kovacs K, Stefaneanu L, Horvath E & Cheng Z 1992 S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas. Endocrine Pathology 3 28-38.
24. Matsumoto H, Koyama C, Sawada T, Koike K, Hirota K, Miyake A, Arimura A & Inoue K 1993 Pituirary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotrophic peptidc (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3′,5′-monophosphate and interleukin-6 secretion and cell proliferation. Endocrinology 133 2150-2155.
25. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W & Ullrich A 1993 High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 835-846.
26. Miyata A, Arimura A, Dahl R, Minamino N, Uehara A, Jiang L, Culler MD & Coy DH 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochemical and Biophysical Research Communications 164 567-574.
27. Mustonen T & Ahtalo K 1995 Endothelial receptor tyrosine kinases involved in angiogenesis. Journal of Cell Biology 129 895-898.
28. Nauck M, Roth M, Tamin M, Eickelberg O, Wieland H, Stulz P & Perruchoud AP 1997 Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. American Journal of Respiratory Cell Molecular Biology 16 398-406.
29. Rawlings SR & Hezareh M 1996 Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocrine Reviews 17 4-29.
30. Renner U, Newton CJ, Pagotto U, Sauer J, Arzt E & Stalla GK 1995 Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology 136 3186-3193.
31. Renner U, Gloddek J, Arzt E, Inoue K & Stalla GK 1997 Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells. Experimental and Clinical Endocrinology and Diabetes 105 345-352.
32. Rinehart JF & Farquhar MG 1953 Electron microscopic studies of the anterior pituitary gland. Journal of Histochemistry and Cytochemistry 1 93-113.
33. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jarfe RB & Taylor KN 1996 Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. Journal of Clinical Endocrinology and Metabolism 81 3112-3118.
34. Shweiki D, Itin A, Neufeld G, Gitay-Goren H & Keshet E 1993 Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Journal of Clinical Investigation 91 2235-2243.
35. Soh EY, Sobhi SA, Wong MG, Meng G, Siperstein AE, Clark OH & Duh Q-Y 1996 Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery 120 944-947.
36. Sone H, Okuda Y, Kawakami Y, Kondo S, Hanatani M, Matsuo K, Suzuki H & Yamashita K 1996 Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sciences 59 21-25.
37. Ueta Y, Levy A, Chowdrey HS & Lightman SL 1995 S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas. Journal of Neuroendocrinology 7 467-474.
38. Vankelecom H, Carmeliet P, Van Damme J, Billiau A & Denef C 1989 Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49 102-106.
39. Wilting J & Christ B 1996 Embryogenic angiogenesis: a review. Naturwissenschaften 83 153-164.